Education
About Us
Working with TipRanks
Follow Us
Biotron Limited (AU:BIT)
ASX:BIT
Total Valuation
Biotron has a market cap or net worth of $2.65M. The enterprise value is AU$1.78M.
Market Cap$2.65M
Enterprise ValueAU$1.78M
Share Statistics
Biotron has 1,327,245,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,327,245,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Biotron ’s return on equity (ROE) is 14.08 and return on invested capital (ROIC) is 1470.46%.
Return on Equity (ROE)14.08
Return on Assets (ROA)-6.96
Return on Invested Capital (ROIC)1470.46%
Return on Capital Employed (ROCE)21.11
Revenue Per Employee411.28K
Profits Per Employee-859.13K
Employee Count4
Asset Turnover3.33
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Biotron is -8.96. Biotron ’s PEG ratio is -0.02.
PE Ratio-8.96
PS Ratio0.00
PB Ratio4.34
Price to Fair Value-126.16
Price to FCF14.84
Price to Operating Cash Flow10.95
PEG Ratio-0.02
Income Statement
In the last 12 months, Biotron had revenue of 1.65M and earned -3.44M in profits. Earnings per share was 0.00.
Revenue1.65M
Gross Profit1.65M
Operating Income-5.15M
Pretax Income-5.08M
Net Income-3.44M
EBITDA-5.04M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was 181.99K and capital expenditures -3.07K, giving a free cash flow of 178.92K billion.
Operating Cash Flow181.99K
Free Cash Flow178.92K
Free Cash Flow per Share<0.01
Dividends & Yields
Biotron pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.43
52-Week Price Change-77.08%
50-Day Moving Average0.02
200-Day Moving Average0.03
Relative Strength Index (RSI)37.57
Average Volume (3m)1.60M
Important Dates
Biotron upcoming earnings date is Aug 29, 2025, TBA Not Confirmed.
Last Earnings DateFeb 28, 2025
Next Earnings DateAug 29, 2025
Ex-Dividend Date―
Financial Position
Biotron as a current ratio of 0.58, with Debt / Equity ratio of 0.00%
Current Ratio0.58
Quick Ratio0.58
Debt to Market Cap0.00
Net Debt to EBITDA0.08
Interest Coverage Ratio-4.74K
Taxes
In the past 12 months, Biotron has paid -1.65M in taxes.
Income Tax-1.65M
Effective Tax Rate0.32
Enterprise Valuation
Biotron EV to EBITDA ratio is -6.03, with an EV/FCF ratio of -8.52.
EV to Sales18.48
EV to EBITDA-6.03
EV to Free Cash Flow-8.52
EV to Operating Cash Flow-8.52
Balance Sheet
Biotron has $878.88K in cash and marketable securities with AU$0.00 in debt, giving a net cash position of -$878.88K billion.
Cash & Marketable Securities$878.88K
Total DebtAU$0.00
Net Cash-$878.88K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 98.96%, with operating margin of -313.12%, and net profit margin of -208.89%.
Gross Margin98.96%
Operating Margin-313.12%
Pretax Margin-308.89%
Net Profit Margin-208.89%
EBITDA Margin-306.37%
EBIT Margin-308.83%
Analyst Forecast
The average price target for Biotron is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast64.10%